Search results
Showing 46 to 60 of 166 results for atrial fibrillation
Evidence-based recommendations on percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism. This involves using a special device to block the mouth of the left atrial appendage and stop the blood clot from getting into the bloodstream.
View recommendations for IPG349Show all sections
Sections for IPG349
Atrial fibrillation: pulse rhythm assessment in people at risk (IND168)
This indicator covers the percentage of patients registered at the practice aged 65 years and over who have been diagnosed with 1 or more of the following conditions: coronary heart disease, heart failure, hypertension, diabetes, CKD, PAD, or stroke/TIA who have had a pulse rhythm assessment in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM146
Evidence-based recommendations on thoracoscopic exclusion of the left atrial appendage in atrial fibrillation (with or without other cardiac surgery) for the prevention of thromboembolism. This involves inserting a camera and instruments through small cuts in the chest and closing the left atrial appendage.
View recommendations for IPG400Show all sections
Sections for IPG400
failure: diagnosis and management - To be confirmed Atrial fibrillation: diagnosis and management - To be confirmed Cardiovascular
self‑monitoring coagulation status using point‑of‑care coagulometers for atrial fibrillation and heart valve disease. Guidance
Awaiting development [GID-IPG10267] Expected publication date: 12 June 2025
AcQMap for mapping the heart atria to target ablation treatment for arrhythmias (MIB246)
NICE has developed a medtech innovation briefing (MIB) on AcQMap for mapping the heart atria to target ablation treatment for arrhythmias .
identified patients in each practice with AF who were not treated according to the NICE guidance for Atrial fibrillation...
This guideline covers investigating all suspected thyroid disease and managing primary thyroid disease (related to the thyroid rather than the pituitary gland). It does not cover managing thyroid cancer or thyroid disease in pregnancy. It aims to improve quality of life by making recommendations on diagnosis, treatment, long-term care and support.
Evidence-based recommendations on Zio XT for detecting cardiac arrhythmias.
View recommendations for MTG52Show all sections
postoperative atrial fibrillation: What is the clinical and cost effectiveness of stopping anticoagulation in people whose postoperative...
Question Cognitive behavioural therapy for people with atrial fibrillation: What is the clinical and cost effectiveness of cognitive...
KODEX-EPD for cardiac imaging during ablation of arrhythmias (MIB260)
NICE has developed a medtech innovation briefing (MIB) on KODEX-EPD for cardiac imaging during ablation of arrhythmias .
Recommendation ID NG106/3 Question The impact of atrial fibrillation on the natriuretic peptide threshold for diagnosing heart failure:-...
people with atrial fibrillation: Which automated blood pressure monitors are suitable for people with hypertension and atrial...